Results

Total Results: 22 records

Showing results for "allergy".
Users also searched for: seasonal allergies

  1. cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
    June 07, 2019 - reactions. … Based on the type and severity of a previous allergic reaction, the clinician might want to consider … There is a reminder to ask about allergies to assess the type and severity of the allergic reaction … Verify completeness “confirm allergy status” The provider should evaluate all allergies to determine … Based on the type and severity of the allergic reaction, the antimicrobial might not be absolutely
  2. cds.ahrq.gov/sites/default/files/cds/artifact/686/Clostridium%20difficile%20(C.diff)%20Infection%20Treatment%20Pathway_updated%20March%202019.pdf
    June 20, 2019 - tapered regimen after completing therapy for fulminant CDI Not fulminant YES, Fulminant Intolerance/allergy … to oral vancomycin Intolerance/allergy to oral vancomycin RECURRENT CDI?
  3. cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax_Post_Exposure_Prophylaxis_CDS_Validation_Report.pdf
    October 17, 2018 - If the patient has no allergies, then this Flag resource will be empty. … If the patient has no allergies to latex, then this Flag resource will be empty. … 0.40 Must sum to 1.0 Allergy transition probability: ciprofloxacin allergy 0.15 Allergy transition … probability: doxycycline allergy 0.15 Allergy transition probability: levofloxacin allergy 0.15 … Allergy transition probability: BioThrax® allergy 0.10 Allergy transition probability: latex allergy
  4. cds.ahrq.gov/sites/default/files/workgroups/216/jan-2017-cholesterol-wg-notes.docx
    January 01, 2017 - considerations surrounding the provision of medication recommendations based on cardiovascular risk: · Allergy … this may pose implementation challenges given current reality. · Sophisticated systems would embed allergy
  5. cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
    January 01, 2017 - and exceptions should stop the CDS from presenting any interventions, with the exception of statin allergyAllergies are very rare and side effects can usually be discussed and worked through with the patient
  6. cds.ahrq.gov/sites/default/files/workgroups/226/mar-2017-cholesterol-wg-notes.docx
    January 01, 2017 - . · Aspirin use to prevent cardiovascular disease: · Consider allergy as additional exclusion. · Consider
  7. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM_0.pdf
    September 01, 2022 - eCQM Denominator Exceptions: • Patients with statin-associated muscle symptoms or an allergy to statin … 3 times the normal limit) OR ESRD OR receiving palliative or hospice care OR adverse effect, allergy … eCQM measure states that the denominator excepts patients with statin-associated muscle symptoms or allergy … The CQL logic is unchanged from v4 and still contains adverse effects, allergies, and intolerances. … A value set for muscle symptoms was added and the adverse effects, allergies, and intolerances value
  8. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM.pdf
    September 01, 2022 - eCQM Denominator Exceptions: • Patients with statin-associated muscle symptoms or an allergy to statin … 3 times the normal limit) OR ESRD OR receiving palliative or hospice care OR adverse effect, allergy … eCQM measure states that the denominator excepts patients with statin-associated muscle symptoms or allergy … The CQL logic is unchanged from v4 and still contains adverse effects, allergies, and intolerances. … A value set for muscle symptoms was added and the adverse effects, allergies, and intolerances value
  9. cds.ahrq.gov/sites/default/files/cds/artifact/21/2023_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2023 - Individuals who have an allergy to statin, are receiving palliative or hospice care, who have active … eCQM Denominator Exceptions: • Patients with statin-associated muscle symptoms or an allergy to statin … 3 times the normal limit) OR ESRD OR receiving palliative or hospice care OR adverse effect, allergy … The CQL logic is unchanged from v5; it still contains adverse effects, allergies, and intolerances. … A value set for muscle symptoms was added; the adverse effects, allergies, and intolerances value set
  10. cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2024 - Updated statin allergy value set to include combination drugs containing statins. … Individuals who have an allergy to statin, are receiving palliative or hospice care, who have active … period. 15 eCQM Denominator Exceptions: • Patients with statin-associated muscle symptoms or an allergy … eCQM measure states that the denominator excepts patients with statin-associated muscle symptoms or allergy … The CQL value set and logic differ in that they contain adverse effects, allergies, and intolerances
  11. cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
    October 01, 2017 - Exclusions that were considered, but not included in CDS logic at this time Consider completeness Statin allergy … physicians felt that providers should determine if a statin is withheld based on these concepts, since allergies … Consider completeness Statin allergy and intolerance Cholesterol Management Work Group physicians felt … that providers should determine if a statin is withheld based on these concepts, since allergies and
  12. cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_final.pdf
    January 01, 2020 - Patient has allergy or intolerance to aspirin. g. … currently receiving aspirin (at any dose) OR ordered for or receiving palliative care 18 OR aspirin allergy … Verify Completeness Exclusion: aspirin allergy Aspirin should not be prescribed to an individual
  13. cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_final_2.pdf
    April 01, 2021 - Patient has allergy or intolerance to aspirin. g. … currently receiving aspirin (at any dose) OR ordered for or receiving palliative care 19 OR aspirin allergy … Verify Completeness Exclusion: aspirin allergy Aspirin should not be prescribed to an individual
  14. cds.ahrq.gov/sites/default/files/cds/artifact/26/2023_CDS_Connect_IG_Aspirin_Therapy.pdf
    January 01, 2023 - Patient has allergy or intolerance to aspirin. g. … currently receiving aspirin (at any dose) OR ordered for or receiving palliative care OR aspirin allergy … Verify completeness Exclusion: aspirin allergy Aspirin should not be prescribed to an individual
  15. cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
    January 01, 2024 - Patient has allergy or intolerance to aspirin. g. … currently receiving aspirin (at any dose) OR ordered for or receiving palliative care 14 OR aspirin allergy … Verify completeness Exclusion: aspirin allergy Aspirin should not be prescribed to an individual
  16. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact.pdf
    April 01, 2021 - counted in the denominator or numerator when determining performance on the measure.2 Individuals with allergy … Denominator Exceptions: Patients with adverse effect, allergy, or intolerance to statin medication. … breastfeeding OR breastfeeding observation within the past year 21 OR rhabdomyolysis OR adverse effect, allergy
  17. cds.ahrq.gov/cedar/AHRQ_CEDAR_Environmental_Scan_2020_508.pdf
    January 01, 2020 - Identified Standards or Formats Description NIH National Institute of Allergy and Infectious Disease … Consensus Statements, Practice-related Resources, Coding and Reimbursement American College of Allergy … American College of Allergy, Asthma, and Immunology https://acaai.org/allergies Practice Resources … – Allergies Yes Variable Undetermined Allergy resources include: Types of Allergies, Allergy Treatments … Disorders) P (Cardiovascular System) Health System No Yes No No No Immune System No Yes P (Allergy
  18. cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
    October 01, 2017 - Patient has allergy or intolerance to aspirin. g. Patient has less than 10-year life expectancy. h. … Verify Completeness Exclusion: Aspirin Allergy ASA should not be prescribed to an individual that
  19. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
    October 01, 2017 - Individuals with allergy or intolerance to statin medications, who are receiving palliative care, who … DENOMINATOR EXCEPTIONS: Patients with adverse effect, allergy, or intolerance to statin medication.
  20. cds.ahrq.gov/cedar/AHRQ_CEDAR_Environmental_Scan_2023_508.pdf
    January 01, 2023 - Dawei Lin, PhD (Division of Allergy, Immunology, and Transplantation, NIAID, NIH), and the members of … premier source of drug interaction data; provides detailed information on drug/drug, drug/disease, drug/allergy … National Drug Data File NGC National Guideline Clearinghouse™ NIAID NIH National Institute of Allergy

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: